GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (FRA:BOX) » Definitions » Total Liabilities

Becton Dickinson (FRA:BOX) Total Liabilities : €24,705 Mil (As of Dec. 2023)


View and export this data going back to 1963. Start your Free Trial

What is Becton Dickinson Total Liabilities?

Becton Dickinson's Total Liabilities for the quarter that ended in Dec. 2023 was €24,705 Mil.

Becton Dickinson's quarterly Total Liabilities increased from Jun. 2023 (€24,993.92 Mil) to Sep. 2023 (€25,283.07 Mil) but then declined from Sep. 2023 (€25,283.07 Mil) to Dec. 2023 (€24,704.90 Mil).

Becton Dickinson's annual Total Liabilities increased from Sep. 2021 (€25,672.55 Mil) to Sep. 2022 (€27,928.52 Mil) but then declined from Sep. 2022 (€27,928.52 Mil) to Sep. 2023 (€25,283.07 Mil).


Becton Dickinson Total Liabilities Historical Data

The historical data trend for Becton Dickinson's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson Total Liabilities Chart

Becton Dickinson Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27,860.16 25,679.70 25,672.55 27,928.52 25,283.07

Becton Dickinson Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26,107.26 26,808.60 24,993.92 25,283.07 24,704.90

Becton Dickinson Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Becton Dickinson's Total Liabilities for the fiscal year that ended in Sep. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6222.617+(13809.506+4292.397
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+958.551)
=25,283

Total Liabilities=Total Assets (A: Sep. 2023 )-Total Equity (A: Sep. 2023 )
=49454.86-24171.789
=25,283

Becton Dickinson's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6914.18+(12924.198+4046.721
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+819.798)
=24,705

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=47935.258-23230.361
=24,705

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton Dickinson Total Liabilities Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton Dickinson (FRA:BOX) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.